NCT06344286

Brief Summary

The goal of this clinical trial is to evaluate the effects of minimal enteral nutrition (MEN) on mesenteric blood flow and oxygenation with Doppler USG and Near Infrared Spectroscopy (NIRS) during therapeutic hypo¬thermia (TH) in babies with hypoxic ischemic encephalopathy. The main question it aims to answer is: 1- How do the mesenteric blood flow and oxygenation get affected with MEN during TH? Participants will be either fed with MEN during TH or given placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
Last Updated

April 3, 2024

Status Verified

March 1, 2024

Enrollment Period

2 years

First QC Date

March 12, 2024

Last Update Submit

March 27, 2024

Conditions

Keywords

Therapeutic hypothermiaMinimal enteral nutritionMesenteric oxygenationMesenteric blood flowSplanchnic oxygenationCerebrosplanchnic ratio

Outcome Measures

Primary Outcomes (2)

  • Cerebral and mesenteric blood flow velocities and oxygenation

    Cerebral and mesenteric blood flow velocities with Doppler US

    (From postnatal first day until postnatal 4 th day)Doppler US of SMA and MCA performed before feeding (15-30 minutes before) and 60 minutes after feeding

  • Cerebral and mesenteric rSO2 values

    Cerebral and mesenteric rSO2 values with NIRS

    (From postnatal first day until postnatal 4 th day) Recording of NIRS data was commenced 60minutes before the initiation of TH and was continued during the procedure till 24 hours after cessation of TH

Secondary Outcomes (3)

  • Development of NEC

    From admission to NICU till postnatal 15th day or hospital discharge whichever came first,

  • Feeding intolerance

    From admission to NICU till postnatal 15th day or hospital discharge whichever came first,

  • Time to full enteral feeding

    From admission to NICU till postnatal 15th day or hospital discharge whichever came first,

Study Arms (2)

Infants receiving MEN

ACTIVE COMPARATOR

The babies fed with minimal enteral nutrition during TH constituted the study group

Dietary Supplement: Minimal enteral nutrition

Infants receiving placebo

PLACEBO COMPARATOR

The babies who were given distilled water during TH

Dietary Supplement: Distilled water

Interventions

Minimal enteral nutritionDIETARY_SUPPLEMENT

The babies were randomized into two groups based on whether they received MEN during TH. While the babies fed with MEN during TH constituted the study group, the control group was composed of the babies who were given the same amount of distilled water according to the same protocol. Two groups were compared in terms of demographic characteristics, clinical outcomes, NIRS and Doppler measurements.

Infants receiving MEN
Distilled waterDIETARY_SUPPLEMENT

The babies were randomized into two groups based on whether they received MEN during TH. While the babies fed with MEN during TH constituted the study group, the control group was composed of the babies who were given the same amount of distilled water according to the same protocol. Two groups were compared in terms of demographic characteristics, clinical outcomes, NIRS and Doppler measurements.

Infants receiving placebo

Eligibility Criteria

Age0 Days - 1 Day
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The neonates with evidence of encephalopathy de¬fined by seizures or abnormalities on a modified Sarnat exam were enrolled. The hypoxic-ischemic injury was defined by 1. a pH of ≤ 7.0 and/or 2. base deficit \>-16 mmol/L recorded in cord blood or blood gas obtained within the first hour postnatally or a pH of 7.0 - 7.15 and/or base deficit (-10-15.9) mmol/L with the presence of an acute perinatal event (cord prolapse, placental abruption, heart rate decelerations, severe fetal bradycardia). In cases where criteria 1 or 2 are met, with the presence of seizures or a diagnosis of moderate to severe encephalopathy according to the Sarnat \& Sarnat classification based on neurological examination were treated with TH.

You may not qualify if:

  • Infants with congenital malformation or hereditary metabolic diseases, infants whose enteral feeding was initiated before randomization and infants without lack of parental consent were excluded. The maternal and neonatal demographic characteristics and clinical outcomes were collected from medical records.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IstanbulTRH

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • DİDEM ARMAN

    Istanbul Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
The feeding materials were prepared inside an opaque syringe and serially numbered by Total Parenteral Nutrition Department in our institution. The investigators who made all measurements, examinations and collected data, and the nurses of the babies were blinded. All of the infants in the study group were fed with breast milk during the trial.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: An enteral intake of breast milk with a volume of 10-20 mL/kg/day was defined as minimal enteral feeding. Minimal enteral feeding was initiated at postnatal 24 hours with breast milk via an orogastric tube. A total daily intake of 120 ml/kg/day was defined as full enteral feeding. The babies were randomized into two groups based on whether they received MEN during TH. While the babies fed with MEN during TH constituted the study group, the control group was composed of the babies who were given the same amount of distilled water according to the same protocol. Two groups were compared in terms of demographic characteristics, clinical outcomes, NIRS and Doppler measurements.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 12, 2024

First Posted

April 3, 2024

Study Start

September 1, 2020

Primary Completion

August 31, 2022

Study Completion

October 31, 2022

Last Updated

April 3, 2024

Record last verified: 2024-03

Locations